14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.85 Wednesday, 1st May 2024 NVAX stock ended at $4.67. This is 7.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.89% from a day low at $4.29 to a day high of $4.80.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Aug 21, 2023 $7.25 $8.51 $6.98 $8.07 16 626 178
Aug 18, 2023 $7.33 $7.55 $7.07 $7.14 4 645 393
Aug 17, 2023 $7.15 $7.62 $7.14 $7.37 6 062 430
Aug 16, 2023 $7.15 $7.45 $7.07 $7.13 3 528 747
Aug 15, 2023 $7.15 $7.31 $7.04 $7.24 4 761 355
Aug 14, 2023 $7.30 $7.35 $7.01 $7.24 4 250 747
Aug 11, 2023 $7.69 $7.73 $7.34 $7.36 6 342 911
Aug 10, 2023 $7.16 $8.13 $7.10 $7.69 13 129 102
Aug 09, 2023 $7.44 $7.68 $6.85 $7.12 10 472 242
Aug 08, 2023 $8.12 $8.82 $7.10 $7.23 29 754 072
Aug 07, 2023 $8.08 $8.06 $7.29 $7.52 8 236 530
Aug 04, 2023 $8.24 $8.30 $8.00 $8.06 4 024 155
Aug 03, 2023 $8.48 $8.84 $8.21 $8.23 3 908 624
Aug 02, 2023 $8.62 $8.74 $7.86 $8.40 6 171 024
Aug 01, 2023 $9.14 $9.29 $8.64 $8.75 4 110 334
Jul 31, 2023 $8.25 $9.34 $8.20 $9.28 8 033 429
Jul 28, 2023 $7.99 $8.34 $7.88 $8.20 4 609 614
Jul 27, 2023 $8.25 $8.39 $7.83 $7.85 4 609 163
Jul 26, 2023 $8.02 $8.29 $7.92 $8.22 2 851 758
Jul 25, 2023 $8.00 $8.29 $7.99 $8.00 3 800 497
Jul 24, 2023 $8.27 $8.29 $7.81 $7.97 3 461 442
Jul 21, 2023 $8.20 $8.20 $7.68 $8.15 4 078 210
Jul 20, 2023 $8.16 $8.30 $7.90 $8.06 4 018 409
Jul 19, 2023 $8.15 $8.35 $8.03 $8.11 3 997 646
Jul 18, 2023 $8.13 $8.68 $7.94 $8.11 4 957 328
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT